CN1811430A - Singlet oxygen europium coordination compound fluorescent probe and application thereof - Google Patents
Singlet oxygen europium coordination compound fluorescent probe and application thereof Download PDFInfo
- Publication number
- CN1811430A CN1811430A CN 200510045768 CN200510045768A CN1811430A CN 1811430 A CN1811430 A CN 1811430A CN 200510045768 CN200510045768 CN 200510045768 CN 200510045768 A CN200510045768 A CN 200510045768A CN 1811430 A CN1811430 A CN 1811430A
- Authority
- CN
- China
- Prior art keywords
- fluorescent probe
- singlet oxygen
- coordination compound
- fluorescence
- compound fluorescent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 23
- 229910052693 Europium Inorganic materials 0.000 title claims abstract description 19
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 150000001875 compounds Chemical class 0.000 title claims description 27
- 239000003446 ligand Substances 0.000 claims abstract description 11
- 125000000524 functional group Chemical group 0.000 claims abstract 3
- 239000000523 sample Substances 0.000 claims description 19
- 238000005259 measurement Methods 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 15
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 4
- 238000005558 fluorometry Methods 0.000 claims 3
- HCLXLZGAYCTHQJ-UHFFFAOYSA-N 1h-cyclohepta[b]pyridine Chemical group C1=CC=CC=C2NC=CC=C21 HCLXLZGAYCTHQJ-UHFFFAOYSA-N 0.000 claims 1
- 238000001685 time-resolved fluorescence spectroscopy Methods 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 238000001514 detection method Methods 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000002904 solvent Substances 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 239000007853 buffer solution Substances 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000001914 filtration Methods 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000006862 quantum yield reaction Methods 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 241000726103 Atta Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- OOFLZRMKTMLSMH-UHFFFAOYSA-N H4atta Chemical compound OC(=O)CN(CC(O)=O)CC1=CC=CC(C=2N=C(C=C(C=2)C=2C3=CC=CC=C3C=C3C=CC=CC3=2)C=2N=C(CN(CC(O)=O)CC(O)=O)C=CC=2)=N1 OOFLZRMKTMLSMH-UHFFFAOYSA-N 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 230000008033 biological extinction Effects 0.000 description 4
- 238000003271 compound fluorescence assay Methods 0.000 description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
- 238000002189 fluorescence spectrum Methods 0.000 description 4
- -1 hydrocarbon peroxides Chemical class 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229910021538 borax Inorganic materials 0.000 description 3
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 229910052761 rare earth metal Inorganic materials 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 235000010339 sodium tetraborate Nutrition 0.000 description 3
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 2
- FCNCGHJSNVOIKE-UHFFFAOYSA-N 9,10-diphenylanthracene Chemical compound C1=CC=CC=C1C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 FCNCGHJSNVOIKE-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000002910 rare earth metals Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 2
- AJKVQEKCUACUMD-UHFFFAOYSA-N 2-Acetylpyridine Chemical compound CC(=O)C1=CC=CC=N1 AJKVQEKCUACUMD-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical group N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- YMNKUHIVVMFOFO-UHFFFAOYSA-N anthracene-9-carbaldehyde Chemical compound C1=CC=C2C(C=O)=C(C=CC=C3)C3=CC2=C1 YMNKUHIVVMFOFO-UHFFFAOYSA-N 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 150000002012 dioxanes Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- IMBKASBLAKCLEM-UHFFFAOYSA-L ferrous ammonium sulfate (anhydrous) Chemical compound [NH4+].[NH4+].[Fe+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O IMBKASBLAKCLEM-UHFFFAOYSA-L 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 150000005673 monoalkenes Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- BJDYCCHRZIFCGN-UHFFFAOYSA-N pyridin-1-ium;iodide Chemical compound I.C1=CC=NC=C1 BJDYCCHRZIFCGN-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Plural Heterocyclic Compounds (AREA)
Abstract
本发明涉及一种新型单线态氧铕荧光探针及其应用,是以三价铕离子Eu3+与含有功能性基团的2,2’:6’2”-联三吡啶骨架结构类配位体形成的配合物,其中所述配位体结构式如上,R=H,CnH2n+1,C6H5。这类配合物可通过其功能性基团与单线态氧作用,使配合物的荧光强度发生很大的变化,进而用于单线态氧的荧光测定。
The present invention relates to a novel singlet oxygen europium fluorescent probe and its application. It uses trivalent europium ion Eu 3+ to match with a functional group-containing 2,2':6'2"-biterpyridine skeleton structure. A complex formed by a ligand, wherein the ligand structural formula is as above, R=H, C n H 2n+1 , C 6 H 5 . This type of complex can interact with singlet oxygen through its functional group to make The fluorescence intensity of the complex changes greatly, and then it is used for the fluorescence determination of singlet oxygen.
Description
技术领域technical field
本发明涉及溶液中单线态氧(1O2)的测定技术,具体地说是一种新型1O2铕配合物荧光探针(即基于铕配合物的新型单线态氧荧光探针)及其应用。The present invention relates to the measurement technology of singlet oxygen ( 1 O 2 ) in solution, specifically a novel 1 O 2 europium complex fluorescent probe (that is, a novel singlet oxygen fluorescent probe based on europium complex) and its application.
背景技术Background technique
单线态氧(1O2)是一种氧分子的激发态,它不仅在有机合成中是一种非常有用的氧化剂,而且还具有十分重要的生理活性。在有机合成中,1O2使得在高度立体专一的有机化合物中引入氧变得极为容易。1O2有以下几种重要的反应:首先,1O2可以与单烯烃反应,生成二氧杂环烷烃或烃过氧化物。前者在室温下通常分解为相应的羰基化合物并发光,后者则在相应的条件下生成不饱和酮、烯丙醇或羟基化合物。其次,1O2可以和带有N、O或S等给电子杂原子的活泼双键反应,生成四元的1,2-二氧环,紧接着分裂成二醛类结构的化合物。同时,1O2能够与链状、环状、芳香、杂环芳香型共轭π键发生Diels-Alder型加成反应,生成内氧化物。除此之外,1O2还可与类胡罗卜素、胺类、酚类和杂环类化合物发生较复杂的化学和物理作用,使得1O2在生物体系中具有很高的反应活性。在生命体系中,1O2是生物体中一种常见的活性氧,它性质活泼、亲电子性强,可以与DNA、蛋白质和脂类物质等多种生物分子反应,起着非常重要的生理作用。1O2几乎在所有的生物光氧化系统中作为反应前体产生,是生物细胞光敏化损伤的主要作用物质。它可以破坏血液中红细胞的细胞膜,使细胞发生溶血;同时还可以与氨基酸作用,抑制羟基脱氢酶和胰岛素的活性。在免疫系统中,1O2是白细胞吞噬、溶解入侵有机体的主要杀菌剂。Singlet oxygen ( 1 O 2 ) is an excited state of oxygen molecule. It is not only a very useful oxidant in organic synthesis, but also has very important physiological activities. In organic synthesis, 1 O 2 makes it extremely easy to introduce oxygen into highly stereospecific organic compounds. 1 O 2 has the following important reactions: First, 1 O 2 can react with monoolefins to generate dioxanes or hydrocarbon peroxides. The former usually decomposes into corresponding carbonyl compounds and emits light at room temperature, while the latter generates unsaturated ketones, allyl alcohol or hydroxyl compounds under corresponding conditions. Secondly, 1 O 2 can react with active double bonds with electron-donating heteroatoms such as N, O, or S to generate quaternary 1,2-dioxo rings, followed by splitting into compounds with dialdehyde structures. At the same time, 1 O 2 can undergo Diels-Alder addition reaction with chain, ring, aromatic and heterocyclic aromatic conjugated π bonds to generate internal oxides. In addition, 1 O 2 can also have complex chemical and physical interactions with carotenoids, amines, phenols and heterocyclic compounds, making 1 O 2 highly reactive in biological systems . In the living system, 1 O 2 is a common active oxygen in organisms. It is active and electrophilic, and can react with various biomolecules such as DNA, protein and lipids, and plays a very important physiological role. effect. 1 O 2 is produced as a reaction precursor in almost all biological photooxidative systems, and is the main substance responsible for photosensitization damage of biological cells. It can destroy the cell membrane of red blood cells in the blood and cause hemolysis; it can also interact with amino acids to inhibit the activity of hydroxyl dehydrogenase and insulin. In the immune system, 1 O 2 is the main bactericide for leukocytes to phagocytose and dissolve invading organisms.
由于1O2具有如此重要的作用,检测1O2、特别是生物体系中的1O2越来越引起人们的关注。从上个世纪70年代开始到现在,1O2的检测主要有以下几种方法:(1)利用1O2自身淬灭1Δg→3∑g-产生的磷光来检测1O2(文献1:A.A.,Jr.Krasnovsky,Biofzika,1976,21,748)。该方法专一性很高,但灵敏度低、检出信号弱,无法用于低浓度1O2的检测。目前,随着检测仪器性能的提高,该方法已经被用于某些生物体系中1O2的产生、生理作用和空间分布的研究(文献2:C.Kiryu,M.Makiuchi,J.Miyazaki,T.Fujinaga,K.Kakinuma,FEBS Lett.1999,443,154;文献3:S.Oelckers,T.Ziegler,I.Michler,B.Rder,J.Photochem.Photobiol.B:Biol.1999,53,121;文献4:L.K.Andersen,P.R.Ogilby,Photochem.Photobiol.2001,73,489;文献5:L.K.Andersen,Z.Gao,P.R.Ogilby,L.Poulsen,I.Zebger,J.Phys.Chem.A 2002,106,8488)。(2)利用1O2与带有蒽环的荧光素类探针分子专一性反应,使得探针由原来的非荧光性分子变为强荧光性分子,从而用于1O2的检测(文献6:N.Umezawa,K.Tanaka,Y.Urano,K.Kikuchi,T.Higuchi,T.Nagano,Angew.Chem.Int.Ed.Engl.1999,38,2899;文献7:K.Tanaka,T.Miura,N.Umezawa,Y.Urano,K.Kikuchi,T.Higuchi,T.Nagano,J.Am.Chem.Soc.2001,123,2530)。该方法检测时间短、灵敏度高,但不适用于低pH值环境和实时检测。(3)利用9,10-二苯基蒽(DPA)与1O2的特征性反应生成稳定的内氧化物,通过测定DPA吸收光谱的改变来测量1O2(文献8:M.J.Stenbeck,A.U.Khan,M.J.Kamovsy,J.Biol.Chem.1992,267,13425;文献9:M.J.Stenbeck,A.U.Khan,M.J.Kamovsy,J.Biol.Chem.1993,268,15649)。该方法已经被用于测定吞噬细胞中产生的1O2,但由于检测基于吸收光谱,所以灵敏度较低。(4)利用1O2与探针分子之间的能量传递,激发探针分子发出强的迟滞荧光,进而用于1O2的检测(文献10:A.A.Jr.Krasnovsky,C.Schweitzer,H.Lesmann,C.Tanielian,E.A.Luk’yanets,Quantum Electron.2000,30,445;文献11:A.A.Jr.Krasnovsky,M.E.Bashtanov,N.N.Drozdova,O.A.Yuzhakova,E.A.Luk’yanets,Quantum Electron.2002,32,83)。该方法适用于多种体系,且发光量子产率是1O2磷光的3-5倍。但检测所用的探针同时敏化1O2的生成,使测定结果产生偏差。(5)一种基于光诱导电子转移过程的化学发光法检测1O2(文献12:X.H.Li,G.X.Zhang,H.M.Ma,D.Q.Zhang,J.Li,D.B.Zhu,J.Am.Chem.Soc.2004,126,11543)。该方法选择性好、灵敏度高、检测迅速,但探针水溶性差,不利于生物体系中1O2的测定。Because 1 O 2 plays such an important role, the detection of 1 O 2 , especially 1 O 2 in biological systems, has attracted more and more attention. From the 1970s to the present, there are mainly the following methods for the detection of 1 O 2 : (1) Use the phosphorescence generated by 1 O 2 self-quenching 1 Δ g → 3 ∑ g - to detect 1 O 2 (Ref. 1: AA, Jr. Krasnovsky, Biofzika, 1976, 21, 748). This method has high specificity, but its sensitivity is low and the detection signal is weak, so it cannot be used for the detection of low concentration 1 O 2 . At present, with the improvement of the performance of detection instruments, this method has been used in the research of the production, physiological effects and spatial distribution of 1 O 2 in some biological systems (document 2: C.Kiryu, M.Makiuchi, J.Miyazaki, T.Fujinaga, K.Kakinuma, FEBS Lett.1999, 443, 154; Literature 3: S.Oelckers, T.Ziegler, I.Michler, BRder, J.Photochem.Photobiol.B: Biol.1999, 53, 121; Literature 4: LKAndersen, PROgilby, Photochem.Photobiol.2001, 73, 489; Literature 5: LKAndersen, Z.Gao, PROgilby, L.Poulsen, I.Zebger, J.Phys.Chem.A 2002, 106, 8488 ). (2) Using 1 O 2 to specifically react with the fluorescein probe molecule with anthracycline, the probe changes from the original non-fluorescent molecule to a strong fluorescent molecule, so that it can be used for the detection of 1 O 2 ( Literature 6: N.Umezawa, K.Tanaka, Y.Urano, K.Kikuchi, T.Higuchi, T.Nagano, Angew.Chem.Int.Ed.Engl.1999, 38, 2899; Literature 7: K.Tanaka, T. Miura, N. Umezawa, Y. Urano, K. Kikuchi, T. Higuchi, T. Nagano, J. Am. Chem. Soc. 2001, 123, 2530). This method has short detection time and high sensitivity, but it is not suitable for low pH environment and real-time detection. (3) Utilize the characteristic reaction of 9,10-diphenylanthracene (DPA) and 1 O 2 to generate stable internal oxides, and measure 1 O 2 by measuring the change of DPA absorption spectrum (Document 8: MJStenbeck, AUKhan, MJ Kamovsy, J. Biol. Chem. 1992, 267, 13425; Document 9: MJ Stenbeck, AU Khan, MJ Kamovsy, J. Biol. Chem. 1993, 268, 15649). This method has been used to measure 1 O 2 produced in phagocytes, but the sensitivity is low because the detection is based on absorption spectra. (4) Using the energy transfer between 1 O 2 and the probe molecule, the probe molecule is excited to emit strong delayed fluorescence, which is then used for the detection of 1 O 2 (document 10: AAJr.Krasnovsky, C.Schweitzer, H.Lesmann , C. Tanielian, EALuk'yanets, Quantum Electron. 2000, 30, 445; Literature 11: AAJr. Krasnovsky, ME Bashtanov, NNDrozdova, OA Yuzhakova, EALuk'yanets, Quantum Electron. 2002, 32, 83). This method is applicable to a variety of systems, and the quantum yield of luminescence is 3-5 times that of 1 O 2 phosphorescence. However, the probe used in the detection is also sensitized to the generation of 1 O 2 , which leads to deviations in the measurement results. (5) A chemiluminescent method for detecting 1 O 2 based on photoinduced electron transfer process (Document 12: XHLi, GXZhang, HMMa, DQZhang, J.Li, DBZhu, J.Am.Chem.Soc.2004, 126, 11543 ). This method has good selectivity, high sensitivity, and rapid detection, but the probe has poor water solubility, which is not conducive to the determination of 1 O 2 in biological systems.
近年来,以稀土荧光配合物为探针的时间分辨荧光测定法已广泛应用于免疫分析、DNA杂交分析、荧光显微生物成像分析等多种测定中。稀土荧光配合物具有荧光寿命长、Stokes位移大、荧光发光峰尖锐等特点,通过使用时间分辨荧光测定法可有效除去各种散乱光和样品本底荧光对荧光测定的影响,从而极大地提高测定灵敏度。In recent years, time-resolved fluorescence assays using rare earth fluorescent complexes as probes have been widely used in various assays such as immunoassay, DNA hybridization analysis, and fluorescence microbiological imaging analysis. Rare earth fluorescent complexes have the characteristics of long fluorescence lifetime, large Stokes shift, and sharp fluorescence peak. By using time-resolved fluorescence measurement method, the influence of various scattered light and sample background fluorescence on fluorescence measurement can be effectively removed, thereby greatly improving the measurement efficiency. sensitivity.
发明内容Contents of the invention
本发明的目的是将时间分辨荧光测定法应用于1O2的检测,提供一种灵敏度高、选择性及水溶性好、适用范围广的新型1O2铕配合物荧光探针。The purpose of the present invention is to apply the time-resolved fluorescence measurement method to the detection of 1 O 2 , and provide a novel 1 O 2 europium complex fluorescent probe with high sensitivity, good selectivity, good water solubility and wide application range.
为实现上述目的,本发明采用的技术方案是:In order to achieve the above object, the technical scheme adopted in the present invention is:
以稀土离子与含有蒽环取代2,2’:6’,2”-联三吡啶骨架结构的配位体形成的荧光探针,其所述配位体结构式为:A fluorescent probe formed by a rare earth ion and a ligand containing an anthracycline-substituted 2,2':6',2"-biteropyridine skeleton structure, the ligand structural formula is:
其中R为氢(H)、烷基(CnH2n+1)或苯基(C6H5);其中最好n=1~6。Wherein R is hydrogen (H), alkyl (CnH 2n+1 ) or phenyl (C 6 H 5 ); wherein n=1-6 is preferred.
本发明的荧光探针能用于多种环境下1O2的测定,在各类生物及非生物环境中,即利用探针捕获体系中产生的1O2,使得探针的荧光强度极大的改变,然后通过测定探针与1O2作用前后荧光强度的变化量来测定1O2的浓度(产生及生成量)。The fluorescent probe of the present invention can be used for the determination of 1 O 2 in various environments. In various biological and non-biological environments, the 1 O 2 produced in the probe capture system is used to make the fluorescence intensity of the probe extremely high Then, the concentration of 1 O 2 (production and production amount) was determined by measuring the change of fluorescence intensity before and after the probe interacted with 1 O 2 .
其中所述的荧光测定法除了常规的荧光测定法外,还包括时间分辨荧光测定法及时间分辨荧光显微镜测定法。The fluorescence assay mentioned therein includes time-resolved fluorescence assay and time-resolved fluorescence microscope assay in addition to conventional fluorescence assay.
本发明铕配合物荧光探针可制备成单线态氧铕配合物荧光探针的1O2检测试剂及试剂盒。The europium complex fluorescent probe of the present invention can be prepared as a 1 O 2 detection reagent and kit for the singlet oxygen europium complex fluorescent probe.
本发明的荧光探针具有如下优点:The fluorescent probe of the present invention has the following advantages:
1.本发明的新型1O2荧光探针具有很好的水溶性,适用于生物体系中1O2的测定。1. The novel 1 O 2 fluorescent probe of the present invention has good water solubility and is suitable for the determination of 1 O 2 in biological systems.
2.本发明的新型1O2荧光探针稳定性高,能长期保存使用,适用于弱酸性、中性及碱性等多种环境。2. The novel 1 O 2 fluorescent probe of the present invention has high stability, can be stored and used for a long time, and is suitable for various environments such as weak acidity, neutrality and alkalinity.
3.本发明的新型1O2荧光探针具有极高的灵敏度,其最低检测限比已报道的化学发光方法低28倍。3. The novel 1 O 2 fluorescent probe of the present invention has extremely high sensitivity, and its lowest detection limit is 28 times lower than that of the reported chemiluminescence method.
4.本发明的新型1O2荧光探针对1O2有很好的选择性,与其他的活性氧物种作用荧光信号几乎无变化。4. The novel 1 O 2 fluorescent probe of the present invention has good selectivity to 1 O 2 , and the fluorescent signal hardly changes when interacting with other reactive oxygen species.
附图说明Description of drawings
图1为铕配合物1O2荧光探针的结构式;Fig. 1 is the structural formula of europium complex 1 O 2 fluorescent probes;
图2为配位体ATTA的合成路线;Fig. 2 is the synthetic route of ligand ATTA;
图3为含有蒽环取代2,2’:6’,2”-联三吡啶骨架结构配位体的合成路线;Figure 3 is a synthetic route for ligands containing anthracycline-substituted 2,2':6',2"-biterpyridine skeleton structure;
图4为ATTA-Eu3+(实线,1.0μmol/L)和EP-ATTA-Eu3+(虚线,1.0μmol/L)在pH值9.1的0.05mol/L硼酸缓冲溶液中的荧光光谱;Fig. 4 is the fluorescence spectrum of ATTA-Eu 3+ (solid line, 1.0 μ mol/L) and EP-ATTA-Eu 3+ (dotted line, 1.0 μ mol/L) in the 0.05mol/L boric acid buffer solution of pH value 9.1;
图5为EP-ATTA-Eu3+(1.0μmol/L)在不同pH值的0.05mol/L Tris-HCl缓冲溶液中的荧光强度(●)和荧光寿命(○);Figure 5 is the fluorescence intensity (●) and fluorescence lifetime (○) of EP-ATTA-Eu 3+ (1.0 μmol/L) in 0.05mol/L Tris-HCl buffer solution of different pH values;
图6为EP-ATTA-Eu3+(■)和荧光素(□)在pH值9.1的0.05mol/L硼酸缓冲溶液中的光稳定性实验结果;Fig. 6 is the photostability experiment result of EP-ATTA-Eu 3+ (■) and fluorescein (□) in the 0.05mol/L boric acid buffer solution of pH value 9.1;
图7为使用ATTA-Eu3+检测Na2MoO4/H2O2体系中定量产生的1O2的工作曲线。Fig. 7 is a working curve for detecting quantitatively produced 1 O 2 in the Na 2 MoO 4 /H 2 O 2 system using ATTA-Eu 3+ .
具体实施方式Detailed ways
下面通过实施例对本发明作进一步说明。Below by embodiment the present invention will be further described.
实施例1.配位体[4’-(9-蒽基)-2,2’:6’2”-联三吡啶-6,6”-二甲胺]四乙酸(简称ATTA)的合成。Example 1. Synthesis of ligand [4'-(9-anthracenyl)-2,2':6'2"-biteropyridine-6,6"-dimethylamine]tetraacetic acid (ATTA for short).
合成路线如图2所示,基体操作过程如下。The synthetic route is shown in Figure 2, and the matrix operation process is as follows.
(1)(E)-3-(9-蒽基)-1-(2’-吡啶基)-2-丙烯酮(化合物1)的合成(1) Synthesis of (E)-3-(9-anthracenyl)-1-(2'-pyridyl)-2-propenone (compound 1)
将10.31克9-蒽醛(50mmol)和2.81克KOH(50mmol)混合溶于200ml甲醇与40ml水组成的混合溶液中;搅拌30分钟后,缓慢滴加6.06克2-乙酰基吡啶(50mmol)于反应体系中,室温下搅拌24小时;过滤收集沉淀,粗产品用乙醇重结晶;得目标化合物12.77克,产率:82.6%。1H NMR(CDCl3)测定结果:δ=8.48-8.54(m,5H);7.92(m,1H);8.03(d,J=8.4Hz,2H);8.27-8.31(m,2H);8.37(d,J=8.0Hz,2H);8.48(s,1H);8.70(d,J=4.4Hz,1H);8.93(d,J=16.0Hz,1H)。10.31 grams of 9-anthral (50mmol) and 2.81 grams of KOH (50mmol) were mixed and dissolved in a mixed solution composed of 200ml of methanol and 40ml of water; after stirring for 30 minutes, 6.06 grams of 2-acetylpyridine (50mmol) was slowly added dropwise to The reaction system was stirred at room temperature for 24 hours; the precipitate was collected by filtration, and the crude product was recrystallized from ethanol; 12.77 g of the target compound was obtained, with a yield of 82.6%. 1 H NMR (CDCl 3 ) measurement results: δ=8.48-8.54 (m, 5H); 7.92 (m, 1H); 8.03 (d, J=8.4Hz, 2H); 8.27-8.31 (m, 2H); 8.37 (d, J = 8.0 Hz, 2H); 8.48 (s, 1H); 8.70 (d, J = 4.4 Hz, 1H); 8.93 (d, J = 16.0 Hz, 1H).
(2)4’-(9-蒽基)-2,2’:6’,2”-联三吡啶(化合物2)的合成(2) Synthesis of 4'-(9-anthracenyl)-2,2':6',2"-biterpyridine (compound 2)
在500ml干燥甲醇中加入15.47克化合物1,16.46克[2-(2’-吡啶基)-2-氧代乙基]吡啶碘化物(50mmol)和23.12克干燥的醋酸铵,反应液回流搅拌24小时;减压蒸除溶剂,残留物用400ml氯仿抽提;蒸除氯仿后,粗产品用硅胶柱层析分离,用2∶1的石油醚-乙酸乙酯做洗脱剂,收集第二个组份;产品用乙腈洗涤,真空干燥,得目标化合物5.48克,产率:26.8%。1H NMR(CDCl3)测定结果:δ=7.26-7.37(m,4H);7.47(t,J=7.6Hz,2H);7.71(d,J=8.8Hz,2H);7.92(m,2H);8.07(d,J=8.8Hz,2H);8.55(s,1H);8.61(s,2H);8.63(d,J=4.0Hz,2H);8.79(d,J=8.0Hz,2H)。元素分析结果,计算值:C 85.06%,H 4.68%,N 10.26%;实测值:C 84.66%,H 4.63%,N 9.90%。In 500ml of dry methanol, add 15.47 grams of
(3)6,6”-二腈基-4’-(9-蒽基)-2,2’:6’,2”-联三吡啶(化合物3)的合成(3) Synthesis of 6,6"-dicyano-4'-(9-anthracenyl)-2,2':6',2"-biterpyridine (compound 3)
将3.3克化合物2(8.0mmol)和6.9克80%的间氯过氧化苯甲酸(32.0mmol)溶于160ml二氯甲烷中,室温下搅拌24小时;有机相用150ml 10%的Na2CO3溶液洗涤两遍,无水硫酸钠干燥后,减压蒸除溶剂,真空干燥;将上述得到的产品与6.34克Me3SiCN(64.0mmol)溶于200ml CH2Cl2中,室温下搅拌1小时后,缓慢滴加入5.62克苯甲酰氯(40.0mmol),室温下搅拌24小时;减压蒸除溶剂,加入200ml 10%K2CO3溶液,室温下搅拌1小时;过滤收集沉淀,粗产品用乙腈洗涤;得目标化合物2.34克,产率:63.6%。1H NMR(CDCl3)测定结果:δ=7.40(t,J=7.2Hz,2H);7.50(t,J=8.0Hz,2H);7.63(d,J=8.8Hz,2H);7.75(d,J=7.2Hz,2H);8.05-8.12(m,4H);8.61(s,1H);8.72(s,2H);8.98(d,J=8.0Hz,2H)。3.3 grams of compound 2 (8.0mmol) and 6.9 grams of 80% m-chloroperoxybenzoic acid (32.0mmol) were dissolved in 160ml of dichloromethane and stirred at room temperature for 24 hours ; The solution was washed twice, dried over anhydrous sodium sulfate, the solvent was evaporated under reduced pressure, and dried under vacuum; the product obtained above and 6.34 g of Me 3 SiCN (64.0 mmol) were dissolved in 200 ml of CH 2 Cl 2 and stirred at room temperature for 1 hour Finally, slowly add 5.62 g of benzoyl chloride (40.0 mmol) dropwise, and stir at room temperature for 24 hours; evaporate the solvent under reduced pressure, add 200ml of 10% K 2 CO 3 solution, and stir for 1 hour at room temperature; Washing with acetonitrile; 2.34 g of the target compound was obtained, yield: 63.6%. 1 H NMR (CDCl 3 ) measurement results: δ=7.40(t, J=7.2Hz, 2H); 7.50(t, J=8.0Hz, 2H); 7.63(d, J=8.8Hz, 2H); 7.75( d, J = 7.2 Hz, 2H); 8.05-8.12 (m, 4H); 8.61 (s, 1H); 8.72 (s, 2H); 8.98 (d, J = 8.0 Hz, 2H).
(4)4’-(9-蒽基)-2,2’:6’,2”-联三吡啶-6,6”-二甲酸二甲酯(化合物4)的合成(4) Synthesis of 4'-(9-anthracenyl)-2,2':6',2"-biterpyridine-6,6"-dicarboxylic acid dimethyl ester (compound 4)
将1.89克化合物3(4.1mmol)溶于12ml浓硫酸、24ml冰醋酸和6ml水配成的混合溶液中,85-90℃下搅拌12小时;反应液到入500ml冰水中,过滤收集沉淀,真空干燥;Dissolve 1.89 g of compound 3 (4.1 mmol) in a mixed solution of 12 ml of concentrated sulfuric acid, 24 ml of glacial acetic acid, and 6 ml of water, and stir for 12 hours at 85-90° C.; the reaction solution is poured into 500 ml of ice water, and the precipitate is collected by filtration and vacuum dry;
将4.11克SOCl2(34.6mmol)在冰浴下缓慢加入到125ml干燥的甲醇中,搅拌20分钟后,加入上述水解产物,搅拌回流24小时;减压蒸除溶剂,加入100ml 10%的Na2CO3溶液中,过滤收集沉淀,真空干燥;粗产品用硅胶柱层析分离,用95∶5的氯仿-甲醇洗脱,收集第一个组分;得目标化合物1.56克,产率:72.4%。1H NMR(CDCl3)测定结果:δ=3.90(s,6H);7.36(t,J=8.8Hz,2H);7.50(t,J=7.2Hz,2H);7.66(d,J=8.8Hz,2H);8.06-8.12(m,4H);8.19(d,J=8.0Hz,2H);8.61(s,1H);8.73(s,2H);8.99(d,J=7.2Hz,2H)。Slowly add 4.11 grams of SOCl 2 (34.6 mmol) into 125 ml of dry methanol under ice bath, stir for 20 minutes, add the above-mentioned hydrolyzate, stir and reflux for 24 hours; evaporate the solvent under reduced pressure, add 100 ml of 10% Na 2 In CO 3 solution, the precipitate was collected by filtration and dried in vacuo; the crude product was separated by silica gel column chromatography, eluted with 95:5 chloroform-methanol, and the first fraction was collected; 1.56 g of the target compound was obtained, yield: 72.4% . 1 H NMR (CDCl 3 ) measurement results: δ=3.90(s, 6H); 7.36(t, J=8.8Hz, 2H); 7.50(t, J=7.2Hz, 2H); 7.66(d, J=8.8 Hz, 2H); 8.06-8.12(m, 4H); 8.19(d, J=8.0Hz, 2H); 8.61(s, 1H); 8.73(s, 2H); 8.99(d, J=7.2Hz, 2H ).
(5)6,6”-二羟甲基4’-(9-蒽基)-2,2’:6’,2”-联三吡啶(化合物5)的合成(5) Synthesis of 6,6"-dimethylol 4'-(9-anthracenyl)-2,2':6',2"-biterpyridine (compound 5)
将1.52克化合物4(2.9mmol)溶于48ml无水乙醇中,搅拌形成悬浊液;加入0.44克NaBH4(11.6mmol)室温下搅拌2小时,再回流搅拌8小时;减压蒸除溶剂,加入8ml饱和NaHCO3溶液加热至沸;冷却后加入60ml水,过滤收集沉淀,粗产品用水和乙腈洗涤,真空干燥;得目标化合物1.02克,产率:74.9%。1H NMR(CDCl3)测定结果:δ=4.74(s,4H);7.25(d,J=7.8Hz,2H);7.36(t,J=7.8Hz,2H);7.48(t,J=7.8Hz,2H);7.67(d,J=8.0Hz,2H);7.90(t,J=7.8Hz,2H);8.09(d,J=8.8Hz,2H);8.58(s,1H);8.60(s,2H);8.68(d,J=8.0Hz,2H)。Dissolve 1.52 g of compound 4 (2.9 mmol) in 48 ml of absolute ethanol, and stir to form a suspension; add 0.44 g of NaBH 4 (11.6 mmol) and stir at room temperature for 2 hours, then reflux and stir for 8 hours; evaporate the solvent under reduced pressure, Add 8ml of saturated NaHCO 3 solution and heat to boiling; add 60ml of water after cooling, collect the precipitate by filtration, wash the crude product with water and acetonitrile, and dry in vacuo; 1.02g of the target compound is obtained, yield: 74.9%. 1 H NMR (CDCl 3 ) measurement results: δ=4.74(s, 4H); 7.25(d, J=7.8Hz, 2H); 7.36(t, J=7.8Hz, 2H); 7.48(t, J=7.8 Hz, 2H); 7.67(d, J=8.0Hz, 2H); 7.90(t, J=7.8Hz, 2H); 8.09(d, J=8.8Hz, 2H); 8.58(s, 1H); 8.60( s, 2H); 8.68 (d, J = 8.0 Hz, 2H).
(6)6,6”-二溴甲基-4’-(9-蒽基)-2,2’:6’,2”-联三吡啶(化合物6)的合成(6) Synthesis of 6,6"-dibromomethyl-4'-(9-anthracenyl)-2,2':6',2"-biterpyridine (compound 6)
在40ml无水DMF中加入1.21克PBr3(4.5mmol),室温下搅拌15分钟后加入0.84克化合物5(1.8mmol),继续搅拌24小时;反应结束后加入饱和NaHCO3溶液中和,过滤收集沉淀,粗产品用水和乙腈洗涤,真空干燥;得目标化合物0.83克,产率:77.9%。1H NMR(CDCl3)测定结果:δ=4.52(s,4H);7.38(t,J=7.8Hz,2H);7.49(m,4H);7.70(d,J=7.8Hz,2H);7.92(t,J=7.8Hz,2H),;8.10(d,J=8.0Hz,2H);8.59(s,1H);8.65(s,2H);8.70(d,J=8.0Hz,2H)。Add 1.21 grams of PBr 3 (4.5 mmol) to 40 ml of anhydrous DMF, stir at room temperature for 15 minutes, add 0.84 grams of compound 5 (1.8 mmol), and continue stirring for 24 hours; after the reaction, add saturated NaHCO 3 solution for neutralization, and collect by filtration Precipitate, the crude product was washed with water and acetonitrile, and dried in vacuo; 0.83 g of the target compound was obtained, yield: 77.9%. 1 H NMR (CDCl 3 ) measurement results: δ=4.52(s, 4H); 7.38(t, J=7.8Hz, 2H); 7.49(m, 4H); 7.70(d, J=7.8Hz, 2H); 7.92(t, J=7.8Hz, 2H); 8.10(d, J=8.0Hz, 2H); 8.59(s, 1H); 8.65(s, 2H); 8.70(d, J=8.0Hz, 2H) .
(7)4’-(9-蒽基)-2,2’:6’,2”-联三吡-6,6”-二甲胺四乙酸乙酯(化合物7)的合成(7) Synthesis of 4'-(9-anthracenyl)-2,2':6',2"-tripyr-6,6"-dimethylaminetetraacetic acid ethyl ester (compound 7)
将0.60克化合物6(1mmol)、0.42克二乙酸乙酯基胺(2.2mmol)和1.38克无水K2CO3(10mmol)加入70ml干燥的乙腈和21ml干燥的四氢呋喃配成的混合溶液中,搅拌回流24小时;过滤除去不溶物,减压蒸除溶剂;将生成物溶于100ml氯仿中,用相同体积的饱和NaHCO3及水洗涤。有机相用无水硫酸钠干燥,减压蒸除溶剂后用硅胶柱层析分离,淋洗剂为2∶1∶0.3的石油醚-乙酸乙酯-三乙胺,收集第一个组份;减压蒸除溶剂后产品用少量石油醚洗涤,真空干燥;得目标化合物0.55克,产率:68.0%。1H NMR(CDCl3)测定结果:δ=1.07(t,J=7.2Hz,12H);3.58(s,8H);3.97-4.02(m,12H);7.37(t,J=8.0Hz,2H);7.48(t,J=7.2Hz,2H);7.64(d,J=8.0Hz,2H);7.72(d,J=7.2Hz,2H);7.90(t,J=8.0Hz,2H);7.72(d,J=8.0Hz,2H);8.57(s,3H);7.72(d,J=8.0Hz,2H)。Add 0.60 g of compound 6 (1 mmol), 0.42 g of ethyl diacetate amine (2.2 mmol) and 1.38 g of anhydrous K 2 CO 3 (10 mmol) into a mixed solution prepared by 70 ml of dry acetonitrile and 21 ml of dry tetrahydrofuran, Stir and reflux for 24 hours; remove insoluble matter by filtration, and evaporate the solvent under reduced pressure; dissolve the resultant in 100ml of chloroform, and wash with the same volume of saturated NaHCO 3 and water. The organic phase was dried with anhydrous sodium sulfate, evaporated to remove the solvent under reduced pressure, and then separated by silica gel column chromatography. The eluent was 2:1:0.3 petroleum ether-ethyl acetate-triethylamine, and the first component was collected; After distilling off the solvent under reduced pressure, the product was washed with a small amount of petroleum ether and dried in vacuo; 0.55 g of the target compound was obtained with a yield of 68.0%. 1 H NMR (CDCl 3 ) measurement results: δ=1.07(t, J=7.2Hz, 12H); 3.58(s, 8H); 3.97-4.02(m, 12H); 7.37(t, J=8.0Hz, 2H ); 7.48(t, J=7.2Hz, 2H); 7.64(d, J=8.0Hz, 2H); 7.72(d, J=7.2Hz, 2H); 7.90(t, J=8.0Hz, 2H); 7.72 (d, J=8.0 Hz, 2H); 8.57 (s, 3H); 7.72 (d, J=8.0 Hz, 2H).
(8)[4’-(9-蒽基)-2,2’:6’,2”-联三吡啶-6,6”-二甲胺]四乙酸(ATTA)的合成(8) Synthesis of [4'-(9-anthracenyl)-2,2':6',2"-tripyridine-6,6"-dimethylamine]tetraacetic acid (ATTA)
将1.39克化合物7(1.7mmol)溶于60ml乙醇和10ml水配成的混合溶液中,再加入2.02克KOH(36.0mmol),回流搅拌2小时;减压蒸除溶剂后,产物溶于30ml水中,用1∶1的盐酸调pH值至3左右,室温下搅拌3小时;过滤收集沉淀,用水、乙腈充分洗涤;得目标化合物0.81克,产率:65.6%。1H NMR(DMSO-d6)测定结果:δ=3.45(s,8H);3.96(s,4H);7.47(t,J=8.0Hz,2H);7.56-7.63(m,4H);7.80(d,J=8.0Hz,2H);8.08(t,J=8.0Hz,2H);8.23(t,J=8.0Hz,2H);8.43(s,2H);8.69(d,J=8.0Hz,2H);8.82(s,1H)。元素分析结果,按C39H33N5O8·1.5H2O计算值:C 64.64%,H 4.99%,N 9.64%;实测值:C 64.52%,H 5.38%,N 9.30%。ESI-MS:m/z(%):698(100)M--H]。Dissolve 1.39 g of compound 7 (1.7 mmol) in a mixed solution of 60 ml of ethanol and 10 ml of water, then add 2.02 g of KOH (36.0 mmol), and stir at reflux for 2 hours; after decompression to remove the solvent, the product is dissolved in 30 ml of water , adjusted the pH value to about 3 with 1:1 hydrochloric acid, and stirred at room temperature for 3 hours; the precipitate was collected by filtration, washed with water and acetonitrile; 0.81 g of the target compound was obtained, and the yield was 65.6%. 1 H NMR (DMSO-d 6 ) measurement results: δ=3.45(s, 8H); 3.96(s, 4H); 7.47(t, J=8.0Hz, 2H); 7.56-7.63(m, 4H); 7.80 (d, J=8.0Hz, 2H); 8.08(t, J=8.0Hz, 2H); 8.23(t, J=8.0Hz, 2H); 8.43(s, 2H); 8.69(d, J=8.0Hz , 2H); 8.82(s, 1H). Elemental analysis results, calculated by C 39 H 33 N 5 O 8 ·1.5H 2 O: C 64.64%, H 4.99%, N 9.64%; measured values: C 64.52%, H 5.38%, N 9.30%. ESI-MS: m/z (%): 698 (100) M - -H].
实施例2. 10-甲基-9-蒽基及10-苯基-9-蒽基取代[2,2’:6’,2”-联三吡啶-6,6”-二甲胺]四乙酸配位体的合成Example 2. 10-methyl-9-anthracenyl and 10-phenyl-9-anthracenyl substituted [2,2':6',2"-biterpyridine-6,6"-dimethylamine] tetra Synthesis of acetic acid ligand
合成路线如图3所示,合成操作方法与实施例1相同。The synthetic route is shown in Figure 3, and the synthetic operation method is the same as in Example 1.
实施例3. 配位体ATTA与Eu3+的配合物(简称ATTA-Eu3+)与1O2的反应Example 3. The reaction of the complex of ligand ATTA and Eu 3+ (abbreviated as ATTA-Eu 3+ ) with 1 O 2
将36mg ATTA(0.05mmol)和18mg EuCl3·6H2O(0.05mmol)溶于pH值10.5的NaHCO3-NaOH缓冲溶液中,室温下搅拌2小时后,加入1.2gNa2MoO4·2H2O(5mmol)和500μl30%H2O2,再搅拌30分钟;观测反应液的荧光强度变化,继续加入H2O2,直至反应液荧光强度不再变化;用HCl将反应液的pH值调到3左右,过滤收集沉淀,水洗后真空干燥;ATTA-Eu3+与1O2反应生成的内氧化物(简称EP-ATTA-Eu3+)经ESI-MS确定:ESI-MS:m/z(%):882(10)[M--H]。Dissolve 36mg ATTA (0.05mmol) and 18mg EuCl 3 ·6H 2 O (0.05mmol) in NaHCO 3 -NaOH buffer solution with a pH value of 10.5, stir at room temperature for 2 hours, then add 1.2gNa 2 MoO 4 ·2H 2 O (5mmol) and 500μl 30% H 2 O 2 , and stirred for another 30 minutes; observe the change in the fluorescence intensity of the reaction solution, and continue to add H 2 O 2 until the fluorescence intensity of the reaction solution does not change; use HCl to adjust the pH value of the reaction solution to 3 or so, the precipitate was collected by filtration, washed with water and dried in vacuum; the internal oxide formed by the reaction of ATTA-Eu 3+ and 1 O 2 (referred to as EP-ATTA-Eu 3+ ) was determined by ESI-MS: ESI-MS: m/z (%): 882(10) [M - -H].
实施例4. 探针ATTA-Eu3+及其与1O2结合生成的内氧化物EP-ATTA-Eu3+的荧光性质测定Example 4. Determination of the fluorescence properties of the probe ATTA-Eu 3+ and the internal oxide EP-ATTA-Eu 3+ formed by combining with 1 O 2
(1)荧光光谱、荧光强度及荧光寿命(1) Fluorescence spectrum, fluorescence intensity and fluorescence lifetime
用pH值9.1的0.05mol/L硼酸钠缓冲溶液为溶剂测定了ATTA-Eu3+在该溶剂中的紫外可见光谱、荧光光谱、摩尔消光系数(ε)、荧光量子收率(φ)及荧光寿命(τ)。EP-ATTA-Eu3+由ATTA-Eu3+与Na2MoO4/H2O2在pH值10.5的0.1mol/LNaHCO3-NaOH缓冲溶液中制备,再用pH值9.1的0.05mol/L硼酸钠缓冲溶液稀释10倍后,测定其在该溶剂中的荧光性质。紫外可见光谱测定用仪器为天美UV7500分光光度计。荧光测定仪器为Perkin Elmer LS 50B荧光分光光度计;荧光量子产率测定使用4’-苯基-2,2’:6’,2”-联三吡-6,6”-二甲胺四乙酸铕的配合物作为标准物测得(文献13:M.Latva,H.Takalo,V.M.Mukkala,C.Matachescu,J.C.Rodriguez-Ubis,J.Kankare,J.Lumin.,1997,75,149-169),计算式为φ1=I1ε2C2φ2/I2ε1C1,式中I2、ε2、C2、φ2为标准物的荧光强度、摩尔消光系数、浓度和荧光量子收率,I1、ε1、C1、φ1为待测物的荧光强度、摩尔消光系数、浓度和荧光量子产率。Using a 0.05mol/L sodium borate buffer solution with a pH value of 9.1 as a solvent, the UV-visible spectrum, fluorescence spectrum, molar extinction coefficient (ε), fluorescence quantum yield (φ) and fluorescence of ATTA-Eu 3+ in this solvent were measured. Lifetime (τ). EP-ATTA-Eu 3+ is prepared by ATTA-Eu 3+ and Na 2 MoO 4 /H 2 O 2 in 0.1mol/L NaHCO 3 -NaOH buffer solution with pH value 10.5, and then with 0.05mol/L pH value 9.1 After the sodium borate buffer solution was diluted 10 times, its fluorescence properties in the solvent were measured. The instrument used for the determination of ultraviolet-visible spectrum is Tianmei UV7500 spectrophotometer. The fluorescence measurement instrument is a Perkin Elmer LS 50B fluorescence spectrophotometer; the fluorescence quantum yield measurement uses 4'-phenyl-2,2':6',2"-bitripyr-6,6"-dimethylaminetetraacetic acid The europium complex was measured as a standard (document 13: M.Latva, H.Takalo, VMMukkala, C.Matachescu, JCRodriguez-Ubis, J.Kankare, J.Lumin., 1997, 75, 149-169), calculated The formula is φ 1 =I 1 ε 2 C 2 φ 2 /I 2 ε 1 C 1 , where I 2 , ε 2 , C 2 , and φ 2 are the fluorescence intensity, molar extinction coefficient, concentration and fluorescence quantum yield of the standard. I 1 , ε 1 , C 1 , and φ 1 are the fluorescence intensity, molar extinction coefficient, concentration and fluorescence quantum yield of the analyte.
测定结果见表1。The measurement results are shown in Table 1.
表1.ATTA-Eu3+和EP-ATTA-Eu3+在硼酸钠缓冲溶液中的吸收及荧光性质Table 1. Absorption and fluorescence properties of ATTA-Eu 3+ and EP-ATTA-Eu 3+ in sodium borate buffer solution
由表1可见,探针ATTA-Eu3+与1O2反应前后其荧光强度发生了很大的变化,ATTA-Eu3+荧光很弱,而EP-ATTA-Eu3+具有很强的荧光。两种化合物的荧光光谱如图4所示。It can be seen from Table 1 that the fluorescence intensity of the probe ATTA-Eu 3+ has changed greatly before and after the reaction with 1 O 2 , the fluorescence of ATTA-Eu 3+ is very weak, while the fluorescence of EP-ATTA-Eu 3+ is very strong . The fluorescence spectra of the two compounds are shown in Fig. 4.
(2)溶液pH值对EP-ATTA-Eu3+荧光性质的影响(2) Effect of solution pH on the fluorescence properties of EP-ATTA-Eu 3+
将EP-ATTA-Eu3+用不同pH值的0.05mol/L Tris-HCl缓冲溶液溶解,测定其在不同pH值下的荧光强度和荧光寿命,其结果见图5;由图可见,在pH值大于3的范围内,EP-ATTA-Eu3+的荧光强度和荧光寿命受pH值的影响不大,表明该探针在弱酸性、中性和弱碱性环境中均可使用。Dissolve EP-ATTA-Eu 3+ with 0.05mol/L Tris-HCl buffer solution with different pH values, and measure its fluorescence intensity and fluorescence lifetime at different pH values. The results are shown in Figure 5; it can be seen from the figure that at pH In the range where the value is greater than 3, the fluorescence intensity and fluorescence lifetime of EP-ATTA-Eu 3+ are not greatly affected by the pH value, indicating that the probe can be used in weakly acidic, neutral and weakly alkaline environments.
(3)EP-ATTA-Eu3+的光稳定性(3) Photostability of EP-ATTA-Eu 3+
分别将荧光素和EP-ATTA-Eu3+的水溶液在30W的氘灯下照射65分钟,每隔5分钟记录一次荧光强度,结果如图6所示;由图6可以看出EP-ATTA-Eu3+比荧光素类探针具有更好的光稳定性,更加适用于生物体系中1O2的荧光显微镜成像测定。The aqueous solutions of fluorescein and EP-ATTA-Eu 3+ were irradiated under a 30W deuterium lamp for 65 minutes, and the fluorescence intensity was recorded every 5 minutes. The results are shown in Figure 6; it can be seen from Figure 6 that EP-ATTA- Eu 3+ has better photostability than fluorescein probes, and is more suitable for fluorescence microscopy imaging of 1 O 2 in biological systems.
实施例5.使用ATTA-Eu3+定量测定Na2MoO4/H2O2体系产生的1O2 Example 5. Quantitative determination of 1 O 2 produced by Na 2 MoO 4 /H 2 O 2 system using ATTA-Eu 3+
在pH值10.5的0.1mol/L NaHCO3-NaOH缓冲溶液中分别加入ATTA-Eu3+(100nmol/L)、Na2MoO4(10mmol/L)和一系列浓度的H2O2(该体系中每2分子的H2O2产生1分子的1O2);37℃下放置18小时后对反应液进行时间分辨荧光测定。测定用仪器为Wallac Victor 1420多标记计数仪(Perkin Elmer Life Sciences公司产),测定条件为:激发波长,340nm;检测波长,615nm;延迟时间,0.2ms;窗口时间,0.4ms;循环时间,1.0ms。Add ATTA-Eu 3+ (100nmol/L), Na 2 MoO 4 (10mmol/L) and a series of concentrations of H 2 O 2 to a 0.1mol/L NaHCO 3 -NaOH buffer solution with a pH value of 10.5 (the
如图7所示,1O2的量与荧光强度具有很好的线性关系,说明1O2可被探针ATTA-Eu3+定量检测。用本底信号标准偏差的3倍计算最低检出限,得ATTA-Eu3+对1O2的最低检出限为2.8nmol/L,比已报道的化学发光方法低28倍。As shown in Figure 7, the amount of 1 O 2 has a good linear relationship with the fluorescence intensity, indicating that 1 O 2 can be quantitatively detected by the probe ATTA-Eu 3+ . Using 3 times the standard deviation of the background signal to calculate the minimum detection limit, the minimum detection limit of ATTA-Eu 3+ for 1 O 2 is 2.8nmol/L, which is 28 times lower than the reported chemiluminescence method.
实施例6.ATTA-Eu3+对1O2的选择性检出Example 6. Selective detection of ATTA-Eu 3+ to 1 O 2
在含有100nmol/LATTA-Eu3+的pH值8.4的0.1mol/L NaHCO3缓冲溶液中分别加入10μmol/L H2O2,10μmol/L H2O2和10μmol/L硫酸亚铁铵(·OH)及10μmol/L KO2(O2 -),然后观测其荧光变化;探针ATTA-Eu3+与上述活性氧成分作用后,荧光强度分别增加了12%,76%和6%,远小于1O2(增加1246%),说明ATTA-Eu3+对1O2具有非常高的选择性。Add 10 μmol/L H 2 O 2 , 10 μmol/L H 2 O 2 and 10 μmol/L ferrous ammonium sulfate (OH) to 0.1 mol/L NaHCO 3 buffer solution at pH 8.4 containing 100 nmol/LATTA-Eu 3+ and 10μmol/L KO 2 (O 2 - ), and then observe its fluorescence change; after the probe ATTA-Eu 3+ reacted with the above active oxygen components, the fluorescence intensity increased by 12%, 76% and 6%, which was far less than 1 O 2 (1246% increase), indicating that ATTA-Eu 3+ has a very high selectivity for 1 O 2 .
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510045768 CN1811430A (en) | 2005-01-26 | 2005-01-26 | Singlet oxygen europium coordination compound fluorescent probe and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510045768 CN1811430A (en) | 2005-01-26 | 2005-01-26 | Singlet oxygen europium coordination compound fluorescent probe and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1811430A true CN1811430A (en) | 2006-08-02 |
Family
ID=36844472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510045768 Pending CN1811430A (en) | 2005-01-26 | 2005-01-26 | Singlet oxygen europium coordination compound fluorescent probe and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1811430A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102277155A (en) * | 2011-06-28 | 2011-12-14 | 中国科学院福建物质结构研究所 | Preparation method and application of organic white light-emitting material L-COOH |
| CN102329264A (en) * | 2011-06-28 | 2012-01-25 | 中国科学院福建物质结构研究所 | Preparation and application of organic white light emitting material L-Cl |
| CN102732246A (en) * | 2012-06-15 | 2012-10-17 | 大连理工大学 | Europium complex singlet oxygen fluorescent probe with cell membrane permeability and its application |
| CN105566363A (en) * | 2016-01-04 | 2016-05-11 | 辽宁大学 | Rare earth coordination polymer based on tripod flexible ligand, preparation method and applications thereof |
| CN105917215A (en) * | 2013-11-19 | 2016-08-31 | 凯米罗总公司 | Method for analysing a sample comprising at least a first and a second scale inhibitor |
| CN111693500A (en) * | 2020-06-19 | 2020-09-22 | 哈尔滨工业大学 | Method for realizing monitoring of singlet oxygen quantum yield based on time-resolved spectral measurement |
-
2005
- 2005-01-26 CN CN 200510045768 patent/CN1811430A/en active Pending
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102277155A (en) * | 2011-06-28 | 2011-12-14 | 中国科学院福建物质结构研究所 | Preparation method and application of organic white light-emitting material L-COOH |
| CN102329264A (en) * | 2011-06-28 | 2012-01-25 | 中国科学院福建物质结构研究所 | Preparation and application of organic white light emitting material L-Cl |
| CN102277155B (en) * | 2011-06-28 | 2014-10-15 | 中国科学院福建物质结构研究所 | Preparation method and application of organic white light-emitting material L-COOH |
| CN102329264B (en) * | 2011-06-28 | 2015-03-04 | 中国科学院福建物质结构研究所 | Preparation and application of organic white light emitting material L-Cl |
| CN102732246A (en) * | 2012-06-15 | 2012-10-17 | 大连理工大学 | Europium complex singlet oxygen fluorescent probe with cell membrane permeability and its application |
| CN105917215A (en) * | 2013-11-19 | 2016-08-31 | 凯米罗总公司 | Method for analysing a sample comprising at least a first and a second scale inhibitor |
| US10241047B2 (en) | 2013-11-19 | 2019-03-26 | Kemira Oyj | Method for analysing a sample comprising at least a first and a second scale inhibitor |
| CN105917215B (en) * | 2013-11-19 | 2019-05-31 | 凯米罗总公司 | Method for analyzing a sample comprising at least first and second antiscalants |
| CN105566363A (en) * | 2016-01-04 | 2016-05-11 | 辽宁大学 | Rare earth coordination polymer based on tripod flexible ligand, preparation method and applications thereof |
| CN111693500A (en) * | 2020-06-19 | 2020-09-22 | 哈尔滨工业大学 | Method for realizing monitoring of singlet oxygen quantum yield based on time-resolved spectral measurement |
| CN111693500B (en) * | 2020-06-19 | 2022-11-25 | 哈尔滨工业大学 | Method for realizing monitoring of singlet oxygen quantum yield based on time-resolved spectral measurement |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103666456B (en) | A class of boron fluoride complexed dipyrromethene fluorescent probes, its preparation method and application | |
| US20120282703A1 (en) | Specific detection of d-glucose by a tetraphenylethene-base fluorescent sensor | |
| CN112442056B (en) | Fluorescent probe for simultaneously detecting hypochlorous acid and peroxynitrite anions, and synthetic method and application thereof | |
| CN103865522B (en) | A kind of fluorescent molecular probe and the application in sulfurated hydrogen detection thereof | |
| CN102516992A (en) | A fluorescent probe for detecting Hg2+ ions and its synthesis method and application | |
| CN111624338B (en) | A preparation method of photoelectrochemical immunosensor for detecting prostate specific antigen | |
| CN106892947A (en) | One kind contains(Hydrazinocarbonyl)Complex of iridium of ferrocene ligands and its preparation method and application | |
| CN106749093A (en) | Fluorescent probe for detecting palladium ions, preparation method and application | |
| CN108088825A (en) | A kind of fluorescent chemicals and its synthetic method for formaldehyde examination and the application in Ratio-type fluorescent test paper | |
| CN108752373A (en) | A kind of fluorescence probe identifying hydrogen peroxide based on benzene boron ester | |
| CN108929233A (en) | A kind of fluorescence probe and its preparation method and application of the detection hydrogen peroxide based on aggregation-induced emission characteristic | |
| CN1811430A (en) | Singlet oxygen europium coordination compound fluorescent probe and application thereof | |
| CN104448254B (en) | A kind of containing porphyrin platinum complex phosphorescent conjugated polyelectrolyte photoelectric material and its preparation method and application | |
| US20230365859A1 (en) | Novel electrochemiluminescence co-reactant, electrolyte solution and electrochemiluminescence system comprising same | |
| CN101712866B (en) | Nanometer europium fluorescent particle with performance of visible light excitation, preparation method and application thereof | |
| CN116554010A (en) | Diphenyl ether derivative capable of specifically recognizing tryptophan as well as preparation method and application thereof | |
| CN109021000B (en) | Fluorescent probe for detecting hydrogen peroxide, synthetic method and application | |
| CN1181156C (en) | Rare earth fluorescent markers and their applications | |
| CN102731479B (en) | Organic ligand, rare earth organic fluorescent probe material thereof and preparation method thereof | |
| CN115925646A (en) | Fluorescent probe for detecting mercury ions, solid-state sensing film and its preparation and application | |
| CN117362197B (en) | A dicyandiamide fluorescent probe, its synthesis method and application | |
| CN108484414A (en) | A kind of formaldehyde fluorescence probe and formaldehyde examination piece and preparation method thereof based on tetraphenylethylene, formaldehyde examination piece application method | |
| CN110590784B (en) | Derivative based on pyrrolopyrroledione and preparation method and application thereof | |
| CN102391162A (en) | Three fluorescence complexes formed on basis of Eu (III) and chlorosulfonation four-tooth Beta-diketone ligands and application thereof | |
| Cui et al. | Design and synthesis of a terbium (III) complex-based luminescence probe for time-gated luminescence detection of mercury (II) Ions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |